Skip to main content
S 916 115th Congress Senate Health Drug trafficking and controlled substances Emergency medical services and trauma care Health information and medical records Health personnel Licensing and registrations

Protecting Patient Access to Emergency Medications Act of 2017

Introduced: April 24, 2017 Introduced by: Cassidy, Bill Republican · Louisiana See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 12 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 25, 2018
Held at the desk.
May 25, 2018
Received in the House.
May 24, 2018
Message on Senate action sent to the House.
May 23, 2018
Passed Senate with an amendment and an amendment to the Title by Unanimous Consent. (text: CR S2882-2884)
May 23, 2018
Passed/agreed to in Senate: Passed Senate with an amendment and an amendment to the Title by Unanimous Consent.(text: CR S2882-2884)
May 23, 2018
The committee substitute withdrawn by Unanimous Consent.
May 23, 2018
Measure laid before Senate by unanimous consent. (consideration: CR S2882-2884)
May 1, 2017
Placed on Senate Legislative Calendar under General Orders. Calendar No. 46.
May 1, 2017
Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.
Apr 26, 2017
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Apr 24, 2017
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Apr 24, 2017
Introduced in Senate
 Amendments to this bill 2

Amendments propose changes to this bill. Members vote on amendments separately before the final bill vote. An agreed amendment becomes part of the bill; a failed amendment does not.

2 agreed to

AmendmentSponsorPurposeStatusLatest action
SAMDT 2,268 Cassidy, Bill To amend the title. Agreed to May 23, 2018
SAMDT 2,267 Cassidy, Bill In the nature of a substitute. Agreed to May 23, 2018
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Protecting Patient Access to Emergency Medications Act of 2017

(Sec. 2) This bill amends the Controlled Substances Act to direct the Drug Enforcement Administration (DEA) to register an emergency medical services (EMS) agency to administer controlled substances if the agency submits an application demonstrating that it is authorized to conduct such activity in the state in which the agency practices. The DEA may deny an application if it determines that the registration is inconsistent with the public interest.

An EMS agency may obtain a single registration in each state instead of a separate registration for each location.

A registered EMS agency may deliver, store, and receive controlled substances, subject to specified conditions.

An EMS professional of a registered EMS agency may administer controlled substances in schedules II, III, IV, or V outside the physical presence of a medical director if such administration is authorized under state law and pursuant to a standing or verbal order, subject to specified conditions.

The bill specifies that a hospital-based EMS agency (i.e., an EMS agency owned or operated by a hospital) may continue to administer controlled substances under the hospital's DEA registration.

(Sec. 3) A pharmacy may deliver a controlled substance to an administering practitioner in accordance with this bill's requirements, subject to specified conditions.

The Government Accountability Office must report to Congress on access to and the potential diversion of controlled substances administered by injection, implantation, or through the use of an intrathecal pump.

What's happening now May 25, 2018

Held at the desk.

 Related & companion bills 3
  • HR 5202 Related bill Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018
  • S 2680 Related bill Opioid Crisis Response Act of 2018
  • HR 304 Related bill Protecting Patient Access to Emergency Medications Act of 2017
 Bill text 3 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 9
All 9 Democratic 5 Republican 3 Independent 1
D
Whitehouse, Sheldon
Rhode Island · Oct 23, 2017
 D
Klobuchar, Amy
Minnesota · Aug 2, 2017
 D
Blumenthal, Richard
Connecticut · Jul 17, 2017
 R
Hoeven, John
North Dakota · Jun 13, 2017
 I
King, Angus S., Jr.
Maine · May 22, 2017
 R
Boozman, John
Arkansas · May 9, 2017
 D
Murray, Patty
Washington · May 1, 2017
 R
Murkowski, Lisa
Alaska · Apr 27, 2017
 D
Bennet, Michael F.
Colorado · Apr 24, 2017
Cite this page click to expand
APA
U.S. Congress. (2026). S. 916: Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018. 115th Congress. Open America. https://openamerica.io/bill/115-S-916/
MLA
"S. 916: Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-916/.
Bluebook (legal)
S. 916, 115th Cong. (2026), https://openamerica.io/bill/115-S-916/.
Markdown link
[S. 916: Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018](https://openamerica.io/bill/115-S-916/)
Report a problem